Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2011-02-08
2011-02-08
Blanchard, David J. (Department: 1643)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C424S133100, C424S139100, C424S141100, C424S150100, C435S069600, C435S070210, C435S320100, C435S326000, C530S387100, C530S387300, C530S388100, C530S388250
Reexamination Certificate
active
07884198
ABSTRACT:
The present invention encompasses monoclonal and chimeric antibodies that bind to lipoteichoic acid of Gram positive bacteria. The antibodies also bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal infection in vivo. The mouse monoclonal antibody has been humanized and the resulting chimeric antibody provides a previously unknown means to diagnose, prevent and/or treat infections caused by gram positive bacteria bearing lipoteichoic acid. This invention also encompasses a peptide mimic of the lipoteichoic acid epitope binding site defined by the monoclonal antibody. This epitope or epitope peptide mimic identifies other antibodies that may bind to the lipoteichoic acid epitope. Moreover, the epitope or epitope peptide mimic provides a valuable substrate for the generation of vaccines or other therapeutics.
REFERENCES:
patent: 4027010 (1977-05-01), Kiselev et al.
patent: 4197290 (1980-04-01), Yoshida
patent: 4235869 (1980-11-01), Schwarzberg
patent: 4318902 (1982-03-01), Stephan
patent: 4425330 (1984-01-01), Norcross et al.
patent: 4460575 (1984-07-01), d'Hinterland et al.
patent: 4482483 (1984-11-01), Curry et al.
patent: 4596769 (1986-06-01), Shockman et al.
patent: 4719290 (1988-01-01), Curry et al.
patent: 4732757 (1988-03-01), Stolle et al.
patent: 4744982 (1988-05-01), Hunter et al.
patent: 4761283 (1988-08-01), Anderson
patent: 4789735 (1988-12-01), Frank et al.
patent: 4830852 (1989-05-01), Marburg et al.
patent: 4888279 (1989-12-01), Zeiger
patent: 4902616 (1990-02-01), Fournier et al.
patent: 4954449 (1990-09-01), Hunter et al.
patent: 4965068 (1990-10-01), Stephan et al.
patent: RE33565 (1991-04-01), Stolle et al.
patent: 5034515 (1991-07-01), Proctor
patent: 5043267 (1991-08-01), Richards
patent: 5055455 (1991-10-01), Pier
patent: 5069896 (1991-12-01), Rogers et al.
patent: 5153312 (1992-10-01), Porro
patent: 5175096 (1992-12-01), Hook et al.
patent: 5354654 (1994-10-01), Ligler et al.
patent: 5440014 (1995-08-01), Hook et al.
patent: 5505945 (1996-04-01), Gristina et al.
patent: 5530101 (1996-06-01), Queen et al.
patent: 5530102 (1996-06-01), Gristina et al.
patent: 5538733 (1996-07-01), Emery et al.
patent: 5545721 (1996-08-01), Carroll et al.
patent: 5571511 (1996-11-01), Fischer
patent: 5585098 (1996-12-01), Coleman
patent: 5624904 (1997-04-01), Krieger et al.
patent: 5652217 (1997-07-01), Hook et al.
patent: 5707627 (1998-01-01), Gristina et al.
patent: 5770208 (1998-06-01), Fattom et al.
patent: 5840846 (1998-11-01), Hook et al.
patent: 5851535 (1998-12-01), Jolivet-Reynaud
patent: 5955074 (1999-09-01), Fischer
patent: 5955078 (1999-09-01), Burnham et al.
patent: 6080407 (2000-06-01), Bucala et al.
patent: 6168790 (2001-01-01), Ulevitch et al.
patent: 6194161 (2001-02-01), Fattom et al.
patent: 6248329 (2001-06-01), Chandrashekar et al.
patent: 6294177 (2001-09-01), Fattom
patent: RE37525 (2002-01-01), Prince et al.
patent: 6355625 (2002-03-01), Pavliak et al.
patent: 6365156 (2002-04-01), Lee
patent: 6372897 (2002-04-01), Colette
patent: 6610293 (2003-08-01), Fischer et al.
patent: 6939543 (2005-09-01), Fischer et al.
patent: 7250494 (2007-07-01), Stinson et al.
patent: 2002/0031528 (2002-03-01), Fattom
patent: 2002/0102262 (2002-08-01), Hook et al.
patent: 2003/0103969 (2003-06-01), Ulevitch et al.
patent: 2003/0119101 (2003-06-01), Burnie et al.
patent: 2003/0235578 (2003-12-01), Stinson et al.
patent: 2004/0013673 (2004-01-01), Fischer et al.
patent: 2004/0052779 (2004-03-01), Stinson et al.
patent: 0724016 (1996-07-01), None
patent: 1-226828 (1989-09-01), None
patent: 89/00999 (1989-02-01), None
patent: 90/03398 (1990-04-01), None
patent: 93/09811 (1993-05-01), None
patent: 93/17044 (1993-09-01), None
patent: 93/19373 (1993-09-01), None
patent: 94/11026 (1994-05-01), None
patent: 96/09321 (1996-03-01), None
patent: 96/23896 (1996-08-01), None
patent: 96/39518 (1996-12-01), None
patent: 97/26010 (1997-07-01), None
Harlow et al., Antibodies: A Laboratory Manual (Cold Spring Harbor Laboratory), pp. iii-ix (1988).
Harlow et al., “Monoclonal Antibodies,” Antibodies: A Laboratory Manual (Cold Spring Harbor Laboratory), Chpt. 6:139-243 (1988).
Ichiman et al., “Cross Protection of Mice with the Smith Diffuse Strain ofStaphylococcus aureusversus a type la strain of group B streptococci,” Can. J. Microbiol., vol. 28(7):726-732 (1982).
Ichiman, Y. et al., “Induction of resistance with heat-killed unencapsulated strains ofStaphylococcus epidermidisagainst challenge with encapsulated strains ofStaphylococcus epidermidis,” Microbiol. Immunol., vol. 33(4):277-286 (1989).
Ichiman et al., “Monoclonal IgM Antibody Protection in Mice Against Infection with an Encapsulated Strain ofStaphylococcus epidermidis,” Can. J. Microbiol., vol. 37:404-407 (1991).
Ichiman et al., “Protective Antibodies in Human Sera Against Encapsulated Strains ofStaphylococcus epidermidis,” J. App. Bacter., vol. 63:165-169 (1987).
Ichiman et al., “Relation of Human Serum Antibody AgainstStaphylococcus epidermidisCell Surface Polysaccharide Detected by Enzyme-Linked Immunosorbent Assay to Passive Protection in the Mouse,” J. App. Bacter., vol. 71:176-181 (1991).
Ichiman, Y. et al., “The relationship of capsular-type ofStaphylococcus epidermidisto virulence and induction of resistance in the mouse,” Journal of Applied Bacteriology, vol. 51(2):229-241 (1981).
Jackson, Dianne E. et al., “Monoclonal Antibodies to Immunodeterminants of Lipoteichoic Acids,” Infection and Immunity, vol. 43(3):800-803 (1984).
Jendeberg et al., “Engineering of Fc1 an Fc3 from Human Immunoglobulin G to Analyse Subclass Specificity forStaphylococcalProtein A,” J. Immunol. Methods, vol. 201:25-34 (1997).
Johnsen et al., “Studies on Polysaccharide C ofStaphylococcus epidermidis,” ACTA Path. Microb., vol. 83:226-234 (1975).
Karakawa, W.W. et al., “Immunochemistry of an acidic antigen isolated from aSTaphylococcus aureus,” Journal of Immunology, vol. 114(1pt2):310-315 (1975).
Kelin, “From Harmless Commensal to Invasive Pathogen,” New Engl. J. Med., vol. 323:339-340 (1990).
Klesius, P.H. et al., “Human antibody response to a group AStreptococcal teichoicacid,” Canadian Journal of Microbiology, vol. 20(6):853-859 (1974).
Kojima, Yoshifumi et al., “Antibody to the Capsular Polysaccharide/Adhesin Protects Rabbits against Catheter-Related Bacteremia Due to Coagulase-NegativeStaphylococci,” J. of Infectious Diseases, vol. 162:435-441 (1990).
Kotani et al., “Immunoadjuvant Activities of the Enzymatic Digests of Bacterial Cell Walls Lacking Immunoadjuvancy by Themselves,” Biken Journal, vol. 20:87-90 (1977).
Lamperi et al., “Intraperitoneal Immunoglobulin (Ig) Treatment in Prophylaxis of Bacterial Peritonitis in CAPD,” Biomat., Art. Cells, Art. Org., vol. 15:151-159 (1987).
Lee, “The Prospects for Developing a Vaccine AgainstStaphylococcus aureus,” Trends in Micro., vol. 4:162-166 (1996).
Lehner, T., “Monoclonal antibodies against micro-organisms,” Current Opinion in Immunology, vol. 1(3):462-466 (1989).
Lobuglio et al., “Mouse/Human Chimeric Monoclonal Antibody in Man: Kinetics and Immune Response,” P.N.A.S., vol. 86:4220-4224 (1989).
Losnegard et al., “Immunochemical Studies on Polysacharides fromStaphylococcus epidermidis,” ACTA Path. Microbiol. Scand., vol. 58:493-500 (1963).
Mancuso, Giuseppe et al., “Anti-Lipoteichoic Acid Antibodies Enhance Release of Cytokines by Monocytes Sensitized with Lipoteichoic Acid,” Infection and Immunity, vol. 62(4):1470-1473 (1994).
McDermid et al., “A Procine Model ofStaphylococcus EpidermidisCatheter-Associated Infection,” J. Infect. Dis., vol. 168:897-903 (1993).
Modun et al., “A Preparation ofStaph. epidermidisVaccine by Enzymatic Digestion of Bacterial Cells,” J. Appl. Bacteriol., vol. 67:xv-xvi (1989).
Modun et al.,
Fischer Gerald Walter
Schuman Richard F.
Stinson Jeffrey R.
Wong Hing
Altor Bioscience Corporation
Blanchard David J.
Mandragouras Esq. Amy E.
Nelson Mullins Riley & Scarborough LLP
The Henry M. Jackon Foundation for the Advancement of Military M
LandOfFree
Polynucleotides encoding humanized and chimeric antibodies... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polynucleotides encoding humanized and chimeric antibodies..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polynucleotides encoding humanized and chimeric antibodies... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2624235